Redwood, California -- Medical device technology company Capnia has secured $3.1 million in new equity venture capital investment, according to an SEC regulatory filing.
Capnia has developed a monitoring system that measures carbon monoxide levels in the exhaled breath of infants.
Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.
A total of three investors participated in the offering.
Capnia is still seeking $10.6 million in additional equity funding, according to the filing.